JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• Articles •     Next Articles

Effect of sesquiterpenoids on proliferation activity of prostate cancer cells

WANG Xiao-ling1，KONG Feng1，XU Ai-hui1，JI Kai2，CAI Jie1，REN Kai1，YUAN Hui-qing1   

  1. 1. Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan 250012, China； 2. Grade Five of Clinical Medicine (6 years), School of Medicine, Shandong University, Jinan 250012, China
  • Received:2007-09-07 Revised:1900-01-01 Online:2007-12-24 Published:2007-12-24
  • Contact: YUAN Hui-qing

PDF (PC)

738

Abstract: Objective To investigate the effects of sesquiterpenoids on proliferation of prostate cancer cells. MethodsThe growth of prostate cancer cells treated with sesquiterpenoids from myrrh was determined by MTT. The cell cycle was analyzed by flow cytometry. Also the expressions of p21WAF/CIP1(p21)（p21） and cyclinD at mRNA levels were determined by reverse transcription PCR (RT-PCR). ResultsThe two sesquiterpenoids significantly inhibited the proliferation of prostate cancer cells and caused a G0/G1 arrest, also it induced the expression of p21 and decreased the expression of cyclinD. ConclusionOverexpression of p21 and decrease of cyclinD might contribute to the two sesquiterpenoidmediated inhibitory effects on prostate cancer cell growth.

Key words: Myrrh, Sesquiterpenoid, Prostate cancer, Cell lines, p21, CyclinD

CLC Number: 

  • R963
[1] XU Yaning, ZHANG Xianglin, LIU Xiaoyu, GUO Haiyang. Construction of endogenous epitope-tagged H1FX cell lines and the chromatin distribution mapping [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 1-9.
[2] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
[3] XU Zhen, DIAO Tongxiang, ZANG Zhenjie, SHAO Dingchang, ZHANG Qi, SUN Dingqi, FU Qiang. Value of isoform［-2］proprostate-specific antigen and its derivatives in the diagnosis of prostate cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 51-56.
[4] SHI Benkang, CHEN Shouzhen, QU Sifeng, WANG Yong, LIU Lei. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116.
[5] XU Bing, LI Yong, LIU Ming, LIU Yonghui. Silencing PRRX1 gene expression enhances the sensitivity of prostate cancer resistant cell line PC-3/DTX to docetaxel [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 103-110.
[6] SUN Dingqi, FU Qiang, ZHANG Hui, LIU Shuai, DIAO Tongxiang, CAO Qingwei, ZHANG Keqin. Clinical value of targeted multiparameter MRI and transrectal ultrasonography fusion prostate biopsy for the detection of PI-RADS≥3 prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 108-113.
[7] ZHANG Jiaozhen, LOU Hongxiang. Chemical constituents of Chiloscyphus polyanthus var. rivularis [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 38-41.
[8] LÜ Jiaju, HU Jialin, DING Sentai. Advances in focal therapy for prostate cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 1-5.
[9] ZHOU Fangjian, HUANG Hua, LI Yonghong. Focal cryoablation for prostate cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 6-10.
[10] ZHU Gang, ZHANG Kai. Chinese prostate cancer screening: current situation and challenges [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 11-15.
[11] HAN Bangmin, JING Yifeng. Clinical management of oligometastatic prostate cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 26-29.
[12] YAO Xudong. Strategy and efficacy of surgical treatment in locally advanced prostate cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 21-25.
[13] WANG Haitao. Development of precision medicine in the treatment of castration-resistant prostate cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 30-35.
[14] SU Hengchuan, ZHU Yao, DAI Bo, LIU Chang, HU Silong, YE Dingwei. Significance of 99mTc-PSMA SPECT/CT guided salvage lymph node dissection for prostate cancer patients with biochemical recurrence [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 36-40.
[15] MAO Shaowei, LU Guoliang, LI Liang, XIA Qinghua. Valproic acid augments the anti-tumor potential of metformin in PC-3 cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 48-53.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd